Dr Stephane Mery and Peter Smith of EverQuest Capital Partners present their approach to EIS investing, focusing on technology that can help the UK economy adapt to a changing global environment. They discuss EverQuest's focus on "deep tech" — combining advanced materials, processes and design — and explain how the team assesses investment opportunities, technical risk and potential routes to exit. In the Q&A, chaired by Steve Dobson of GrowthInvest, Stephane and Peter discuss the importance of technical expertise, their relationship with CPR, how potential acquirers are considered from the outset, and how they work with management teams on value creation plans. They also discuss the development of the portfolio to date and the timing of exits in an early-stage investment portfolio. Watch the full event on-demand: https://us06web.zoom.us/webinar/register/1017829083259/WN_3lPsCebMRvCmdzG3JUKxAA Read more on our website and check out our fund reviews here: https://hardmanandco.com/research/tax-advantaged-research/ Key topics covered: EverQuest Capital Partners EIS and deep tech investing UK technology investment Advanced materials and processes Critical supply chains Investment due diligence Technical risk assessment Expert networks and technical expertise Exit strategy Value creation Portfolio performance EIS fund management September 2026 Tax Advantaged Forum: Dr Stephane Mery and Peter Smith, Partners at EverQuest Capital Partners, were speaking at Hardman & Co's Tax Advantaged Forum, hosted in association with GrowthInvest. We also heard from MMC Ventures, Parkwalk and PXN Investments. Important notice: This content has been prepared purely for information purposes, and should not be construed as an offer, or the solicitation of an offer, to buy or sell any security, product, service or investment. Nor should it be viewed as a substitute for viewers’ own due diligence. The companies or legal entities covered in this content may or may not pay us a fixed fee for this content to be made available. This content contains factually correct information at the time of publication which has been provided to us by our client to which the content relates, who have also confirmed that it has not been misleadingly presented. Investing in early-stage growth companies is speculative and involves a high degree of risk. An investor could lose all or a substantial amount of his or her investment, and the securities, legal entities or alternative investments mentioned in this content may not be suitable or appropriate for all investors. Access to liquidity may be totally or highly restricted. Each investor’s particular needs, investment objectives and financial situation were not taken into account in the preparation of this content. Each investor must make his or her own independent decisions and obtain their own independent advice regarding any information, projects, securities, tax treatment or financial instruments mentioned herein. The fact that Hardman & Co has made available through this content various information constitutes neither a recommendation to enter into a particular transaction nor a representation that any financial instrument is suitable or appropriate for you. Each investor should consider whether an investment strategy of the purchase or sale of any product or security is appropriate for them in the light of their investment needs, objectives and financial circumstances. For more information, please read our full disclaimers: www.hardmanandco.com/research-disclosures www.hardmanandco.com/disclaimer #EIS #EISInvesting #DeepTech #VentureCapital #TechnologyInvesting #UKInnovation #GrowthInvesting #EverQuest
